Abstract
The success of allogeneic BMT (allo-BMT) in children with acute leukemias is mainly affected by relapse. There is evidence that these patients have only a little or no benefit from additional immunotherapy if the treatment is started in frank hematological relapse. Recently we were able to demonstrate that pediatric patients with acute leukemias and increasing mixed chimerism (MC) post-transplant have a significantly enhanced risk of developing relapse. We asked whether there is a possibility of preventing relapse, eg by withdrawal of post-tranplant immunosuppression or by administration of donor lymphocytes in an early phase of the development of relapse. We present the case reports of two children (MDS and AML) with rapidly increasing MC in whom withdrawal of post-transplant immunosuppression or donor lymphocyte infusion (DLI) did prevent relapse.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Bader, P., Beck, J., Schlegel, P. et al. Additional immunotherapy on the basis of increasing mixed hematopoietic chimerism after allogeneic BMT in children with acute leukemia: is there an option to prevent relapse?. Bone Marrow Transplant 20, 79–81 (1997). https://doi.org/10.1038/sj.bmt.1700831
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/sj.bmt.1700831
Keywords
This article is cited by
-
Mixed T cell lineage chimerism in acute leukemia/MDS using pre-emptive donor lymphocyte infusion strategy—Is it prognostic?—a single-center retrospective study
Blood Cancer Journal (2021)
-
Quantitative chimerism: an independent acute leukemia prognosis indicator following allogeneic hematopoietic SCT
Bone Marrow Transplantation (2014)
-
Delayed lymphocyte infusion in children given SCT
Bone Marrow Transplantation (2008)
-
A prompt graft-versus-thalassemia effect upon withdrawal of cyclosporine A in a child who received allogeneic peripheral blood stem cell transplantation
Bone Marrow Transplantation (2006)
-
How and when should we monitor chimerism after allogeneic stem cell transplantation?
Bone Marrow Transplantation (2005)